2 - 5 October, 2019

The theme of the 2019 ACTA International Clinical Trials Conference is Better health through best evidence. The conference will provide a platform to bring together national and international stakeholders to discuss global advances in the development of self-improving healthcare systems.

International speakers

  • Derek C. Angus, Distinguished Professor and Mitchell P. Fink Endowed Chair, University of Pittsburgh, United States
  • Barbara Bierer, Professor of Medicine, Harvard Medical School, United States
  • Simon Denegri OBE, National Director for Patients, Carers and the Public in Research, National Institute for Health Research, United Kingdom
  • Neena Modi, Professor of Neonatal Medicine, Imperial College London, United Kingdom
  • Stuart Spencer, Senior Executive Editor, The Lancet, United Kingdom
  • Pamela Tenaerts, Executive Director, Clinical Trial Transformation Initiative, United States

For more information about the event and to register your attendance, click here.

Deadlines

24 June - abstract submission deadline

31 July - early bird registration

About ACTA

The Australian Clinical Trials Alliance's mission is to promote effective and cost‐effective healthcare in Australia through investigator‐initiated clinical trials and clinical quality registries that generate evidence to support decisions made by health practitioners, policy‐makers, and consumers.

Clinical trials networks are collaborative groups of practicing clinician researchers (often several hundred per network) that come together to identify important clinical questions and design large multi-centre clinical trials to answer them. Some also conduct trials in collaboration with industry but the majority have a strong focus on investigator-initiated trials that can provide unbiased, high-quality scientific evidence of the effectiveness or cost effectiveness of interventions.

The CTC's John Simes and Tony Keech are founding members of ACTA. Tony is Convenor of ACTA's 2019 conference.